CHAPEL HILL, N.C., May 7 /PRNewswire/ -- When the unpredictable influenza season returns in the fall, health care officials warn that the seemingly lessening threat of the H1N1 outbreak may worsen. Operating under pandemic contingency plans already, nearly one-third of companies do not have a policy when an employee has come in contact with an ill person outside of their household, according to a Best Practices, LLC primary research study on "Managing Workforce Issues during a Flu-Like Pandemic."
Best Practices, LLC is offering timely, invaluable resources to update or to create your company's disaster management plan. Register at http://www3.best-in-class.com/gr192.htm for a Virtual Roundtable Discussion with like-minded business peers on "Don't Let H1N1 Flu Sabotage 2009: Pandemic Planning for the Well-Prepared Business Leader," Friday, May 15 at 1 p.m. EDT. Cost: $299.
On the Agenda:
- Key Note Speaker: Mike McGuire; Vice President, Anti-Infectives at Roche Pharmaceuticals: Mr. McGuire will share history and key insights from Roche's comprehensive pandemic planning process and speak about employee communication tactics around taking stockpiled vaccines during a pandemic.
- Ronald Mack, MD, MPH, FACEP Corporate Medical Director of Public Service Enterprise Group (PSEG): Dr. Mack will share lessons from his work at PSEG as a thought leader in pandemic preparedness and planning.
- Findings from Primary Field Research by Best Practices, LLC: Following brief expert presentations on corporate preparedness for pandemics, Best Practices researchers will review previous field research that examined the state of corporate pandemic planning.
- Participant Open Discussion: In the final 15 minutes of the Virtual Roundtable Discussion, participants will share their action plans, ask questions of the experts and identify additional organizational issues encountered in responding to the H1N1 outbreak.
Other Preparedness Action Items & Information Resources:
Best Practices, LLC's GLOBAL BENCHMARKING COUNCIL
(http://www3.best-in-class.com/gbc) is an innovative research, benchmarking and networking service for business executives in pharmaceutical and life sciences to promote top-line revenue growth, cost reduction and innovative problem-solving.
For more than a decade, executives have used GLOBAL BENCHMARKING COUNCIL competitive advantages, such as ready access to executives, fast-turnaround research efforts, expansive Best Practice Database and annual networking conferences to refine initiatives, request funding and allocate resources.
Related medicine news :1
. S.C. BlueCross Creates Corporate Planning Unit, Promotes Davis to Vice President2
. Corporate and Political PR Pro to Lead Sudden Cardiac Arrest Association3
. DTI Medical Corporation Announces Reverse Split and Other Corporate Developments4
. Meeting Expectations Named to First Annual CMI 25 List by Corporate Meetings & Incentives Magazine5
. Amylin Pharmaceuticals to Webcast Corporate Overview During 43rd Annual Meeting of the European Association for the Study of Diabetes6
. DSS Research Moves Corporate Office7
. The African Medical and Research Foundation (AMREF) Honors Merck & Co., Inc. with Global Corporate Philanthropy Award8
. Accuray Incorporateds CEO to Speak at UBS Global Life Sciences Conference9
. Eularis Announces New Corporate Name and Expanded Product Offerings10
. AXA Equitable Life Insurance Co. Hires William McDermott to Lead Corporate Retirement Planning Business11
. US Med-Equip Expands Corporate Support Center